Severity score indexes for blistering diseases

被引：76

作者：

Daniel, Benjamin S. ^{[1
,2
]}

Hertl, Michael ^{[3
]}

Werth, Victoria P. ^{[4
,5
]}

Eming, Ruediger ^{[3
]}

Murrell, Dedee F. ^{[1
,2
]}

机构：

[1] St George Hosp, Dept Dermatol, Sydney, NSW, Australia

[2] Univ New S Wales, Dept Dermatol, Sydney, NSW, Australia

[3] Univ Marburg, Dept Dermatol, Marburg, Germany

[4] Philadelphia VA Med Ctr, Dept Dermatol, Philadelphia, PA USA

[5] Univ Penn, Sch Med, Philadelphia, PA 19104 USA

来源：

CLINICS IN DERMATOLOGY | 2012年 / 30卷 / 01期

基金：

美国国家卫生研究院;

关键词：

PEMPHIGUS-VULGARIS; ORAL PEMPHIGUS; IMMUNOADSORPTION; AUTOANTIBODIES; PROGRESSION; ANTIBODIES; RITUXIMAB;

D O I：

10.1016/j.clindermatol.2011.03.017

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Scoring systems are used to assess the severity of a disease and the response to treatment. The main severity scoring indexes are the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and the Pemphigus Disease Area Index (PDAI). They have been validated and are already used in the evaluation of pemphigus and in clinical trials. They quantify disease severity by performing a global assessment of all lesions. In recent years, other severity scoring systems have been developed for pemphigus and other autoimmune blistering diseases. (C) 2012 Elsevier Inc. All rights reserved.

引用

页码：108 / 113

页数：6

共 28 条

[1]

Agarwal M, 1998, INT J DERMATOL, V37, P158

[2] CLINICAL SIGNIFICANCE OF AUTOANTIBODIES IN PEMPHIGUS [J].

CHORZELS.TP ;

VONWEISS, JF ;

LEVER, WF .

ARCHIVES OF DERMATOLOGY, 1966, 93 (05) :570-&

[3] THE CORRELATION OF DISEASE-ACTIVITY AND ANTIBODY-TITERS IN PEMPHIGUS [J].

FITZPATRICK, RE ;

NEWCOMER, VD .

ARCHIVES OF DERMATOLOGY, 1980, 116 (03) :285-290

[4]

Foster C S, 1986, Trans Am Ophthalmol Soc, V84, P527

[5] A REVIEW OF 2 CONTROLLED MULTICENTER TRIALS COMPARING 0.05-PERCENT HALOBETASOL PROPIONATE OINTMENT TO ITS VEHICLE IN THE TREATMENT OF CHRONIC ECZEMATOUS DERMATOSES [J].

GUZZO, CA ;

WEISS, JS ;

MOGAVERO, HS ;

ELLIS, CN ;

ZAIAS, N ;

LOWE, NJ ;

KERDEL, FA ;

MILBAUER, JJ ;

BERNHARD, JD ;

WHITMORE, C ;

URBACH, F ;

LODER, JS ;

GIBSON, JR .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (06) :1179-1183

[6] The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels [J].

Harman, KE ;

Seed, PT ;

Gratian, MJ ;

Bhogal, BS ;

Challacombe, SJ ;

Black, MM .

BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) :775-780

[7] Patterns of remission in pemphigus vulgaris [J].

Herbst, A ;

Bystryn, JC .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) :422-427

[8] Correlation of Immunological Profile with Phenotype and Disease Outcome in Pemphigus [J].

Herrero-Gonzalez, Josep E. ;

Iranzo, Pilar ;

Benitez, Daniel ;

Lozano, Francisco ;

Herrero, Carmen ;

Mascaro, Jose M., Jr. .

ACTA DERMATO-VENEREOLOGICA, 2010, 90 (04) :401-405

[9] History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan [J].

Ikeda, S ;

Imamura, S ;

Hashimoto, I ;

Morioka, S ;

Sakuma, M ;

Ogawa, H .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2003, 295 (Suppl 1) :S12-S16

[10]

Ishii K, 1997, J IMMUNOL, V159, P2010

← 1 2 3 →